Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.

Of 221 patients with breast cancer of known epidermal growth factor receptor (EGFR) and oestrogen receptor (ER) status, 99 had developed recurrences during the period of follow-up (range 3-60 months, median 24 months). Of these, 72 received endocrine therapy as first-line treatment for relapse. Immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, C., Nicholson, S., Angus, B., Sainsbury, J. R., Farndon, J., Cairns, J., Harris, A. L., Horne, C. H.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1992
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977338/
https://www.ncbi.nlm.nih.gov/pubmed/1346366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977338/
https://www.ncbi.nlm.nih.gov/pubmed/1346366

Ejemplares similares